Learning objectives:

 
 
  1. To describe the different types of biomarkers for SLE.
  2. To describe the use of ANA and anti-DNA in the evaluation of patients with SLE and related autoimmune diseases.
  3. To describe the impact of assay variability in using ANA testing to assess eligibility of patients for clinical trials. 
Location: 
Durham, NC
United States
See map: Google Maps
Add to calendar: 
Session date: 
07/10/2018 - 8:00am to 9:00am EDT

Please login or register to take this course.
Room Number: 
3031
Speaker Name: 
Dr. David Pisetsky